Cargando…
Amniotic Fluid Stem Cells for the Treatment of Surgical Disorders in the Fetus and Neonate
Over the past decade, amniotic fluid‐derived stem cells have emerged as a novel experimental approach aimed at improving outcomes in children with congenital anomalies, including spina bifida, heart defects, and diaphragmatic hernia. Interest in these cells for the treatment of prenatally diagnosed...
Autor principal: | Kunisaki, Shaun M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6216434/ https://www.ncbi.nlm.nih.gov/pubmed/30085416 http://dx.doi.org/10.1002/sctm.18-0018 |
Ejemplares similares
-
Intra‐amniotic mesenchymal stem cell therapy improves the amniotic fluid microenvironment in rat spina bifida aperta fetuses
por: Wei, Xiaowei, et al.
Publicado: (2022) -
Amniotic fluid embolism: A puzzling and dangerous obstetric problem
por: Lisonkova, Sarka, et al.
Publicado: (2019) -
Amniotic Fluid Disorders: From Prenatal Management to Neonatal Outcomes
por: Huri, Mor, et al.
Publicado: (2023) -
Sex Differences
in Protein Expression and Their Perturbations
in Amniotic Fluid Cells of Down Syndrome Fetuses
por: Liu, Yanyan, et al.
Publicado: (2022) -
Human amniotic fluid stem cells as a model for functional studies of genes involved in human genetic diseases or oncogenesis
por: Rosner, Margit, et al.
Publicado: (2011)